Inactive Instrument
Cellivery Therapeutics, Inc. Stock
Stocks
A268600
KR7268600004
Biotechnology & Medical Research
| 1 day | -30.43% |
| Manager | Title | Age | Since |
|---|---|---|---|
Dae-Woong Cho
CEO | Chief Executive Officer | 58 | 28/08/2014 |
Byung-Hwa Lee
AUD | Comptroller/Controller/Auditor | 62 | 22/03/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Dae-Woong Cho
BRD | Director/Board Member | 58 | 28/08/2014 |
Yung-Ki Baek
BRD | Director/Board Member | 73 | 31/03/2023 |
Hyung Kim
BRD | Director/Board Member | 40 | 29/03/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -30.43% | -75.38% | - | - | 400K | |
| +3.31% | -0.20% | +72.71% | +128.31% | 55.78B | |
| -1.32% | +17.12% | +79.02% | +99.82% | 55.66B | |
| -1.28% | +2.68% | -12.60% | -13.79% | 23.84B | |
| +1.79% | +4.38% | +5.94% | +405.31% | 22.7B | |
| -1.93% | +11.11% | +34.89% | -7.86% | 18.5B | |
| +4.45% | +5.06% | +36.50% | -30.43% | 16.12B | |
| +0.24% | +5.98% | +23.45% | +184.72% | 13.64B | |
| +0.14% | +9.60% | +33.31% | - | 12.95B | |
| +1.83% | +4.58% | +77.42% | +132.45% | 12.16B | |
| Average | -2.32% | +6.10% | +38.96% | +112.32% | 25.71B | |
| Weighted average by Cap. | +0.80% | +5.21% | +48.48% | +114.84% |
Employees
4
